A method to provide patients with individualized treatment of cancer tumors
This report aims to provide a comprehensive presentation of the global market for Gene Detection for Individualized Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Detection for Individualized Cancer Therapy. This report contains market size and forecasts of Gene Detection for Individualized Cancer Therapy in global, including the following market information:
Global Gene Detection for Individualized Cancer Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Gene Detection for Individualized Cancer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genetic Screening Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gene Detection for Individualized Cancer Therapy include Premed, Yin Feng Gene, United Gene Group, Geneis, Topgen, Annoroad, Gene+, Sanvalley and Sansure, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Detection for Individualized Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Detection for Individualized Cancer Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Gene Detection for Individualized Cancer Therapy Market Segment Percentages, by Type, 2022 (%)
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Global Gene Detection for Individualized Cancer Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Gene Detection for Individualized Cancer Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Diagnostic Center
Global Gene Detection for Individualized Cancer Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Gene Detection for Individualized Cancer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Detection for Individualized Cancer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Detection for Individualized Cancer Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Premed
Yin Feng Gene
United Gene Group
Geneis
Topgen
Annoroad
Gene+
Sanvalley
Sansure
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Detection for Individualized Cancer Therapy, market overview.
Chapter 2: Global Gene Detection for Individualized Cancer Therapy market size in revenue.
Chapter 3: Detailed analysis of Gene Detection for Individualized Cancer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Detection for Individualized Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Detection for Individualized Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Detection for Individualized Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Detection for Individualized Cancer Therapy Overall Market Size
2.1 Global Gene Detection for Individualized Cancer Therapy Market Size: 2022 VS 2030
2.2 Global Gene Detection for Individualized Cancer Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Detection for Individualized Cancer Therapy Players in Global Market
3.2 Top Global Gene Detection for Individualized Cancer Therapy Companies Ranked by Revenue
3.3 Global Gene Detection for Individualized Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Gene Detection for Individualized Cancer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Detection for Individualized Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Detection for Individualized Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Gene Detection for Individualized Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Detection for Individualized Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Detection for Individualized Cancer Therapy Market Size Markets, 2022 & 2030
4.1.2 Genetic Screening
4.1.3 Reproductive Genetic Testing
4.1.4 Diagnostic Test
4.1.5 Gene carrier Test
4.1.6 Testing Before Symptoms Appear
4.2 By Type - Global Gene Detection for Individualized Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Gene Detection for Individualized Cancer Therapy Revenue, 2018-2023
4.2.2 By Type - Global Gene Detection for Individualized Cancer Therapy Revenue, 2024-2030
4.2.3 By Type - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Detection for Individualized Cancer Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Diagnostic Center
5.2 By Application - Global Gene Detection for Individualized Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Gene Detection for Individualized Cancer Therapy Revenue, 2018-2023
5.2.2 By Application - Global Gene Detection for Individualized Cancer Therapy Revenue, 2024-2030
5.2.3 By Application - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gene Detection for Individualized Cancer Therapy Market Size, 2022 & 2030
6.2 By Region - Global Gene Detection for Individualized Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Gene Detection for Individualized Cancer Therapy Revenue, 2018-2023
6.2.2 By Region - Global Gene Detection for Individualized Cancer Therapy Revenue, 2024-2030
6.2.3 By Region - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gene Detection for Individualized Cancer Therapy Revenue, 2018-2030
6.3.2 US Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.3.3 Canada Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.3.4 Mexico Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gene Detection for Individualized Cancer Therapy Revenue, 2018-2030
6.4.2 Germany Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4.3 France Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4.4 U.K. Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4.5 Italy Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4.6 Russia Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.4.8 Benelux Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gene Detection for Individualized Cancer Therapy Revenue, 2018-2030
6.5.2 China Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.5.3 Japan Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.5.4 South Korea Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.5.6 India Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gene Detection for Individualized Cancer Therapy Revenue, 2018-2030
6.6.2 Brazil Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.6.3 Argentina Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Detection for Individualized Cancer Therapy Revenue, 2018-2030
6.7.2 Turkey Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.7.3 Israel Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
6.7.5 UAE Gene Detection for Individualized Cancer Therapy Market Size, 2018-2030
7 Gene Detection for Individualized Cancer Therapy Companies Profiles
7.1 Premed
7.1.1 Premed Company Summary
7.1.2 Premed Business Overview
7.1.3 Premed Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.1.4 Premed Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.1.5 Premed Key News & Latest Developments
7.2 Yin Feng Gene
7.2.1 Yin Feng Gene Company Summary
7.2.2 Yin Feng Gene Business Overview
7.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.2.4 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.2.5 Yin Feng Gene Key News & Latest Developments
7.3 United Gene Group
7.3.1 United Gene Group Company Summary
7.3.2 United Gene Group Business Overview
7.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.3.4 United Gene Group Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.3.5 United Gene Group Key News & Latest Developments
7.4 Geneis
7.4.1 Geneis Company Summary
7.4.2 Geneis Business Overview
7.4.3 Geneis Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.4.4 Geneis Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.4.5 Geneis Key News & Latest Developments
7.5 Topgen
7.5.1 Topgen Company Summary
7.5.2 Topgen Business Overview
7.5.3 Topgen Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.5.4 Topgen Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.5.5 Topgen Key News & Latest Developments
7.6 Annoroad
7.6.1 Annoroad Company Summary
7.6.2 Annoroad Business Overview
7.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.6.4 Annoroad Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.6.5 Annoroad Key News & Latest Developments
7.7 Gene+
7.7.1 Gene+ Company Summary
7.7.2 Gene+ Business Overview
7.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.7.4 Gene+ Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.7.5 Gene+ Key News & Latest Developments
7.8 Sanvalley
7.8.1 Sanvalley Company Summary
7.8.2 Sanvalley Business Overview
7.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.8.4 Sanvalley Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.8.5 Sanvalley Key News & Latest Developments
7.9 Sansure
7.9.1 Sansure Company Summary
7.9.2 Sansure Business Overview
7.9.3 Sansure Gene Detection for Individualized Cancer Therapy Major Product Offerings
7.9.4 Sansure Gene Detection for Individualized Cancer Therapy Revenue in Global Market (2018-2023)
7.9.5 Sansure Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Detection for Individualized Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Gene Detection for Individualized Cancer Therapy Market Drivers in Global Market
Table 3. Gene Detection for Individualized Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Gene Detection for Individualized Cancer Therapy in Global Market
Table 5. Top Gene Detection for Individualized Cancer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Detection for Individualized Cancer Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Detection for Individualized Cancer Therapy Product Type
Table 9. List of Global Tier 1 Gene Detection for Individualized Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Detection for Individualized Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Gene Detection for Individualized Cancer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Detection for Individualized Cancer Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Gene Detection for Individualized Cancer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Detection for Individualized Cancer Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Premed Company Summary
Table 31. Premed Gene Detection for Individualized Cancer Therapy Product Offerings
Table 32. Premed Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Premed Key News & Latest Developments
Table 34. Yin Feng Gene Company Summary
Table 35. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product Offerings
Table 36. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Yin Feng Gene Key News & Latest Developments
Table 38. United Gene Group Company Summary
Table 39. United Gene Group Gene Detection for Individualized Cancer Therapy Product Offerings
Table 40. United Gene Group Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. United Gene Group Key News & Latest Developments
Table 42. Geneis Company Summary
Table 43. Geneis Gene Detection for Individualized Cancer Therapy Product Offerings
Table 44. Geneis Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Geneis Key News & Latest Developments
Table 46. Topgen Company Summary
Table 47. Topgen Gene Detection for Individualized Cancer Therapy Product Offerings
Table 48. Topgen Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Topgen Key News & Latest Developments
Table 50. Annoroad Company Summary
Table 51. Annoroad Gene Detection for Individualized Cancer Therapy Product Offerings
Table 52. Annoroad Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Annoroad Key News & Latest Developments
Table 54. Gene+ Company Summary
Table 55. Gene+ Gene Detection for Individualized Cancer Therapy Product Offerings
Table 56. Gene+ Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Gene+ Key News & Latest Developments
Table 58. Sanvalley Company Summary
Table 59. Sanvalley Gene Detection for Individualized Cancer Therapy Product Offerings
Table 60. Sanvalley Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Sanvalley Key News & Latest Developments
Table 62. Sansure Company Summary
Table 63. Sansure Gene Detection for Individualized Cancer Therapy Product Offerings
Table 64. Sansure Gene Detection for Individualized Cancer Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Sansure Key News & Latest Developments
List of Figures
Figure 1. Gene Detection for Individualized Cancer Therapy Segment by Type in 2022
Figure 2. Gene Detection for Individualized Cancer Therapy Segment by Application in 2022
Figure 3. Global Gene Detection for Individualized Cancer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Detection for Individualized Cancer Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gene Detection for Individualized Cancer Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2022
Figure 8. By Type - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 16. US Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 28. China Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Gene Detection for Individualized Cancer Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Gene Detection for Individualized Cancer Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Premed Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. United Gene Group Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Geneis Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Topgen Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Annoroad Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Gene+ Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanvalley Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sansure Gene Detection for Individualized Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
